>What is the "current recombinant factor VIIa product" and who makes it?<
NovoSeven from NVO.
>How do we just step in and "enable the production and pricing of rhFVIIa at appropriate levels for broader utilization"? What does that mean?<
It means that a transgenically-produced FVIIa is likely to have a lower unit cost than NovoSeven, allowing LFB/GTC to capture market share and potentially expand the market for recombinant FVIIa to prophylactic use in addition to at-need use.
>I would appreciate an in depth discussion on rhFVIIa<
We discussed it a bit last week. Here are a few pointers:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.